DePuy Pinnacle lawsuits: Judge orders J&J’s DePuy Orthopaedics to produce compliance reports

DePuy Pinnacle lawsuits: Judge orders DePuy Orthopaedics to produce compliance reports

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics must produce compliance reports on its metal-on-metal Pinnacle hip implant, ruled the federal judge overseeing the multi-district litigation in Texas last week.

More than 900 cases have been rolled into the MDL in the U.S. District Court for Northern Texas under Judge Ed Kinkeade, accusing DePuy Orthopaedics of negligence, fraudulent misrepresentation and failure to properly design, manufacture, and market the Pinnacle system.

Last week Kinkeade ordered the Warsaw, Ind.-based medical device company to produce "monitor reports" from a court-appointed overseer of DePuy’s compliance with a deferred prosecution agreement with the New Jersey U.S. district attorney, according to court documents.

DePuy had argued that the reports were irrelevant to the Pinnacle lawsuits and not "focused on DePuy’s conduct with respect to the Pinnacle System," according to the documents. But Kinkeade disagreed, ruling that the overseers reports "expressly address issues related to the sale and marketing of hip and knee reconstruction and replacement products which includes the Pinnacle system. The monitor reports are relevant to the marketing and promotional practices related to the Pinnacle system," according to the documents.

"The monitor reports describe the relationships between the defendants and physicians who use or promote DePuy-brand products. The reports detail how DePuy consultants market DePuy products through speaking engagements, resident training courses, and sponsorship of continuing medical education programs at conferences. This information is relevant and could lead to the discovery of admissible evidence on the claims that DePuy failed to correctly warn physicians of Pinnacle system dangers, negligently recommended the product, and supplied false information to physicians," Kinkeade wrote. "Defendants have failed to specifically articulate how production of the monitor reports would be overly burdensome or create an undue hardship."

But the judge denied the plaintiffs’ bid to have supporting documents related to the monitor reports included in the order.

"While the monitor reports themselves are discoverable, at this time, the [plaintiff’s] motion to compel production of underlying documents and information related to or included in the monitor reports is denied without prejudice. The [plaintiff] may re-urge its motion after reviewing the monitor reports, and the defendants arguments regarding burdensomeness and hardship will receive additional analysis by the court, if necessary, based on the specific documents or information being sought," he wrote in the May 15 order.

Kinkeade also ordered that the monitor reports be subject to the confidentiality rules set up by the court earlier in the case.

RSS From Medical Design & Outsourcing

  • Teknor Apex to showcase wide range of PVC compounds for medical devices at Medtec China
    Building on its international leadership role as a supplier of medical-grade PVC compounds, Teknor Apex Company has developed flexible and rigid formulations that address the special needs of device manufacturers. The company will highlight these capabilities at Medtec China 2015. “Teknor Apex produces or markets medical-grade PVC compounds in China, Singapore, Europe, and the United […]
  • The Raspberry Pi eco-system goes interstellar with the new Raspberry Pi Sense HAT
    Newark element14 has globally launched the latest addition to the expanding ecosystem of Raspberry Pi accessories, the Raspberry Pi Sense HAT, as featured in the ‘Astro Pi’ space mission. The Sense HAT will enable enthusiasts to control the same hardware used in space. The Sense HAT attaches to the Raspberry Pi board, and can be […]
  • CommScope completes acquisition of TE Connectivity’s Telecom
    CommScope Holding Company, has completed its previously announced acquisition of TE Connectivity’s Telecom, Enterprise and Wireless businesses, a leader in fiber optic connectivity for wireline and wireless networks. The all-cash transaction, valued at approximately $3 billion, strengthens CommScope’s position as a leading communications infrastructure provider with deeper resources to meet the world’s growing demand for network […]
  • SPI awards IKO Prosthetic Creative System the Student Design International Design Excellence Award
    SPI: The Plastics Industry Trade Association congratulated IKO Prosthetic Creative System for winning the SPI Student Design Award, part of the Industrial Designers Society of America’s (IDSA’s) International Design Excellence Awards (IDEA) program. The award was presented to IKO, an innovative, youth-focused prosthetic design company led by Chicago-based designer Carlos Torres, by SPI’s Senior Director of […]
  • New assay could revolutionize diagnosis and treatment of life-threatening disease
    Invasive Fungal Disease (IFD) is an emerging global health problem associated with high mortality rates in severely immunocompromised patients, such as those undergoing intensive chemotherapy or stem cell transplantation, and in patients suffering immune compromising conditions such as AIDS. The most common causative agents of this disease have been identified as Candida and Aspergillus species, […]
  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]

Leave a Reply